San Antonio Breast Cancer Symposium

圣安东尼奥乳腺癌研讨会

• 批准号: 9353360
• 负责人: Virginia Georgia Kaklamani
• 金额: $ 1万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-15 至 2021-09-13
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9353360
• 关键词: Address; American Association of Cancer Research; Award; Basic Science; Behavior Therapy; Biology; Breast Cancer Patient; Breast Cancer therapy; Breast Diseases; Cancer Biology; Caring; Clinical; Clinical Oncology; Clinical Research; Clinical Trials; Collaborations; Communication; Country; Data; Decision Making; Detection; Diagnosis; Diet; Early Diagnosis; Education; Equilibrium; Etiology; Future; Health Professional; Health Sciences; Institution; International; Knowledge; Learning; Malignant Neoplasms; Medical; Medicine; Mission; NCI Center for Cancer Research; Outcome; Participant; Patients; Physicians; Predisposition; Premalignant; Prevention; Privatization; Quality of life; Research; Research Personnel; Scientist; Slide; Training and Education; Translational Research; Translations; Treatment outcome; Work; anticancer research; cancer prevention; cancer risk; cancer therapy; college; driving force; fight against; improved; insight; interest; lectures; malignant breast neoplasm; meetings; molecular imaging; next generation; outcome forecast; posters; programs; screening; symposium; training opportunity; treatment strategy; tumor

The San Antonio Breast Cancer Symposium (SABCS) is a five day international symposium that provides state-of-the-art information on translational research in breast cancer both for basic scientists and clinicians who work directly with patients. The symposium's aim is to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer to advance the work of fighting against breast cancer. The symposium attracts thought-leaders, academic and private physicians and researchers, as well as other health care professionals focused on curing breast cancer, to discuss and learn about new and late-breaking research including experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and pre-malignant breast disease, as well as new findings from clinical trials. The symposium also attracts young investigators by providing superior education and training opportunities for the next generation of breast cancer researchers. The symposium, now in its thirty-ninth year, is attended by a broad international audience of academic and private researchers and physicians from over 90 countries with an attendance of approximately 8,000. The scientific program consists of plenary lectures and mini-symposia by experts in clinical and basic research; selected slide and poster presentations chosen from the submitted abstracts; educational sessions, award lectures, panel and case discussions, a year in review and both basic science and clinical forums. The symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the shared mission of the organizations to advance progress against breast cancer.

圣安东尼奥乳腺癌研讨会（SABCS）是一个为期五天的国际研讨会， 提供了关于乳腺癌转化研究的最新信息， 科学家和临床医生直接与病人打交道。研讨会的目的是实现一个 平衡临床，转化和基础研究，提供互动论坛， 传播，并为广大研究人员，卫生专业人员， 那些对乳腺癌特别感兴趣的人， 癌 研讨会吸引了思想领袖，学术和私人医生和研究人员， 以及其他专注于治疗乳腺癌的医疗保健专业人员，讨论和学习 关于新的和最新的研究，包括实验生物学，病因学，预防， 乳腺癌和癌前乳腺疾病的诊断和治疗，以及新的 临床试验的结果。研讨会还通过提供 为下一代乳腺癌患者提供上级教育和培训机会 研究人员 该专题讨论会现已进入第三十九个年头， 来自90多个国家的学术和私人研究人员和医生， 大约8000。 科学计划包括全体讲座和小型研讨会的专家在临床和 基础研究;从提交的摘要中选择幻灯片和海报; 教育会议，颁奖讲座，小组和案例讨论，一年的回顾，两者兼而有之 基础科学和临床论坛。 该研讨会由UT健康科学癌症治疗与研究中心主办 中心圣安东尼奥，美国癌症研究协会，贝勒大学 药这种合作背后的驱动力是各组织的共同使命 来推进乳腺癌的治疗